Certain Ordinary Shares of MorphoSys AG are subject to a Lock-Up Agreement Ending on 16-JUL-2022. These Ordinary Shares will be under lockup for 365 days starting from 16-JUL-2021 to 16-JUL-2022. Details: Royalty Pharma has agreed, subject to limited exceptions, not to sell or otherwise transfer any of the new ordinary shares for a period of twelve months.